{"id":null,"code":"DRUG0009","name":{"valueFi":"Therapy Areas in Drug Discovery and Translational Medicine II","valueEn":"Therapy Areas in Drug Discovery and Translational Medicine II","valueSv":"Therapy Areas in Drug Discovery and Translational Medicine II"},"credits":5.0,"minCredits":5,"maxCredits":5,"tags":[],"createdAt":1790534665399,"contentList":[{"title":{"valueFi":"Osaamistavoitteet","valueEn":"Learning outcomes","valueSv":""},"content":{"valueFi":"The aim of the study module is that students can describe pathophysiological disease mechanisms, diagnostic methods and biomarkers as well as clinical symptoms of selected diseases in the main therapy areas. Students master the mechanisrms of action of currently used drugs and are able to critically assess their utility in the treatment of these diseases and identify existing unmet medical needs.\r\nStudents can explain how animal disease models are produced and employed in the development of new drugs and how translational medicine approaches are used to facilitate the entry of drug candidates into clinical development. Students will use databases to evaluate the ongoing clinical trials with novel mechanism of action.\r\nStudents will develop skills that facilitate their ability to communicate effectively and work collaboratively with others.","valueEn":"The aim of the study module is that students can describe pathophysiological disease mechanisms, diagnostic methods and biomarkers as well as clinical symptoms of selected diseases in the main therapy areas. Students master the mechanisrms of action of currently used drugs and are able to critically assess their utility in the treatment of these diseases and identify existing unmet medical needs.\r\nStudents can explain how animal disease models are produced and employed in the development of new drugs and how translational medicine approaches are used to facilitate the entry of drug candidates into clinical development. Students will use databases to evaluate the ongoing clinical trials with novel mechanism of action.\r\nStudents will develop skills that facilitate their ability to communicate effectively and work collaboratively with others.","valueSv":"The aim of the study module is that students can describe pathophysiological disease mechanisms, diagnostic methods and biomarkers as well as clinical symptoms of selected diseases in the main therapy areas. Students master the mechanisrms of action of currently used drugs and are able to critically assess their utility in the treatment of these diseases and identify existing unmet medical needs.\r\nStudents can explain how animal disease models are produced and employed in the development of new drugs and how translational medicine approaches are used to facilitate the entry of drug candidates into clinical development. Students will use databases to evaluate the ongoing clinical trials with novel mechanism of action.\r\nStudents will develop skills that facilitate their ability to communicate effectively and work collaboratively with others."}},{"title":{"valueFi":"Sisältö","valueEn":"Content","valueSv":""},"content":{"valueFi":"The course covers topics from major endocrine and metabolic diseases (like type 2 diabetes and obesity, dyslipidemias, osteoporosis), cancer and oncology, cardiovascular and respiratory diseases (like heart failure, coronary heart disease, asthma, COPD) and autoimmune diseases (like rheumatoid arthritis, psoriasis). \r\n\r\nThe structure and the content of presentations is divided into the following sections:\r\n•\tClinical signs and symptoms and diagnostic criteria\r\n•\tPathophysiological mechanisms and etiology\r\n•\tCurrent drug therapy\r\n•\tAnimal models\r\n•\tEmerging new targets and an overview of the pipeline situation\r\n\r\nEach section is followed by questions and discussions.","valueEn":"The course covers topics from major endocrine and metabolic diseases (like type 2 diabetes and obesity, dyslipidemias, osteoporosis), cancer and oncology, cardiovascular and respiratory diseases (like heart failure, coronary heart disease, asthma, COPD) and autoimmune diseases (like rheumatoid arthritis, psoriasis). \r\n\r\nThe structure and the content of presentations is divided into the following sections:\r\n•\tClinical signs and symptoms and diagnostic criteria\r\n•\tPathophysiological mechanisms and etiology\r\n•\tCurrent drug therapy\r\n•\tAnimal models\r\n•\tEmerging new targets and an overview of the pipeline situation\r\n\r\nEach section is followed by questions and discussions.","valueSv":"The course covers topics from major endocrine and metabolic diseases (like type 2 diabetes and obesity, dyslipidemias, osteoporosis), cancer and oncology, cardiovascular and respiratory diseases (like heart failure, coronary heart disease, asthma, COPD) and autoimmune diseases (like rheumatoid arthritis, psoriasis). \r\n\r\nThe structure and the content of presentations is divided into the following sections:\r\n•\tClinical signs and symptoms and diagnostic criteria\r\n•\tPathophysiological mechanisms and etiology\r\n•\tCurrent drug therapy\r\n•\tAnimal models\r\n•\tEmerging new targets and an overview of the pipeline situation\r\n\r\nEach section is followed by questions and discussions."}},{"title":{"valueFi":"Suoritustavat","valueEn":"Study methods","valueSv":""},"content":{"valueFi":"As the entire study module is based on self-guidance of students and group work, only the main topics are given in advance. Students are divided into groups of four or five. Each group will prepare a presentation on the topic of the week and present their work in seminars. Seminar attendance is mandatory.","valueEn":"As the entire study module is based on self-guidance of students and group work, only the main topics are given in advance. Students are divided into groups of four or five. Each group will prepare a presentation on the topic of the week and present their work in seminars. Seminar attendance is mandatory.","valueSv":""}},{"title":{"valueFi":"Toteutustavat","valueEn":"Course unit methods","valueSv":""},"content":{"valueFi":"Self study, group work, creating and delivering presentations and an examination (approx. 110 h), seminars (20 h).","valueEn":"Self study, group work, creating and delivering presentations and an examination (approx. 110 h), seminars (20 h).","valueSv":""}},{"title":{"valueFi":"Oppimateriaalit","valueEn":"Learning material","valueSv":""},"content":{"valueFi":"Relevant textbooks and recent review articles of the topics. Public databases and pipelines of drug discovery companies.","valueEn":"Relevant textbooks and recent review articles of the topics. Public databases and pipelines of drug discovery companies.","valueSv":""}},{"title":{"valueFi":"Lisätiedot","valueEn":"Further information","valueSv":""},"content":{"valueFi":"Minor students are selected on the basis of their application and previous relevant studies in pharmacology. 1-5 minor students are accepted for the course.","valueEn":"Minor students are selected on the basis of their application and previous relevant studies in pharmacology. 1-5 minor students are accepted for the course.","valueSv":""}},{"title":{"valueFi":"Kurssikirjallisuus","valueEn":"Literature","valueSv":""},"content":{"valueFi":"","valueEn":"","valueSv":""}},{"title":{"valueFi":"Esitietovaatimukset","valueEn":"Qualifications","valueSv":""},"content":{"valueFi":"","valueEn":"","valueSv":""}},{"title":{"valueFi":"Arviointiasteikko","valueEn":"Assessment scale","valueSv":""},"content":{"valueFi":"0-5","valueEn":"0-5","valueSv":"0-5"}},{"title":{"valueFi":"Arviointikriteerit","valueEn":"Assessment criteria","valueSv":""},"content":{"valueFi":"Evaluation criteria are based on:\r\na) the knowledge of the entire area of the study module, as measured by a written examination (60 % of the total grade)\r\nb) the quality of seminar presentations and activity (40 % of the total grade)","valueEn":"Evaluation criteria are based on:\r\na) the knowledge of the entire area of the study module, as measured by a written examination (60 % of the total grade)\r\nb) the quality of seminar presentations and activity (40 % of the total grade)","valueSv":""}},{"title":{"valueFi":"Arviointikriteerit 2","valueEn":"Assessment criteria 2","valueSv":""},"content":{"valueFi":"","valueEn":"","valueSv":""}},{"title":{"valueFi":"Arviointikriteerit 3","valueEn":"Assessment criteria 3","valueSv":""},"content":{"valueFi":"","valueEn":"","valueSv":""}},{"title":{"valueFi":"Arviointikriteerit 4","valueEn":"Assessment criteria 4","valueSv":""},"content":{"valueFi":"","valueEn":"","valueSv":""}},{"title":{"valueFi":"Kielet","valueEn":"Languages","valueSv":""},"content":{"valueFi":"englanti","valueEn":"English","valueSv":"engelska"}},{"title":{"valueFi":"Taso","valueEn":"Level","valueSv":""},"content":{"valueFi":"Syventävät opinnot","valueEn":"Advanced Studies","valueSv":""}},{"title":{"valueFi":"Oppiaine","valueEn":"Subject","valueSv":""},"content":{"valueFi":"Drug Discovery and Development","valueEn":"Drug Discovery and Development","valueSv":"Drug Discovery and Development"}},{"title":{"valueFi":"Vastuuhenkilöt","valueEn":"Person in charge","valueSv":""},"content":{"valueFi":"Sanna Soini","valueEn":"Sanna Soini","valueSv":"Sanna Soini"}},{"title":{"valueFi":"Luokittelu","valueEn":"Classification","valueSv":""},"content":{"valueFi":"","valueEn":"","valueSv":""}},{"title":{"valueFi":"Linkit","valueEn":"Links","valueSv":""},"content":{"valueFi":"","valueEn":"","valueSv":""}}]}